Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization.

ABSTRACT: As part of influenza pandemic preparedness, policy decisions need to be made about how best to utilize vaccines once they are manufactured. Since H5N1 avian influenza virus has the potential to initiate the next human pandemic, isolates of this subtype have been used for the production and testing of prepandemic vaccines. Clinical trials of such vaccines indicate that two injections of preparations containing adjuvant will be required to induce protective immunity. However, this is a working assumption based on classical serological measures only. Examined here are the dose of viral hemagglutinin (HA) and the number of inoculations required for two different H5N1 vaccines to achieve protection in ferrets after lethal H5N1 challenge. Ferrets inoculated twice with 30 microg of A/Vietnam/1194

SUBMITTER: Middleton D 

PROVIDER: S-EPMC2708649 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature